Monday, September 14, 2009

• ZaBeCor Pharmaceuticals Begins Phase II Clinical Trial in Asthma Patients Following Positive Phase I Results

  PHILADELPHIA, PA -- (Marketwire) -- 09/14/09 -- ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung ... read more